Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
CareDx Inc - SIC # 8071 - MEDICAL LABORATORIES
Ticker
Exchange
SIC #
Website
Latest Ticker
CDNA
Nasdaq
8071
https://www.caredx.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for CareDx Inc
CareDx Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
- Apr 19th, 2024 8:05 pm
CareDx (CDNA) Moves 5.5% Higher: Will This Strength Last?
- Apr 18th, 2024 7:47 am
CareDx Appoints John W. Hanna as its New President and Chief Executive Officer
- Apr 16th, 2024 8:02 pm
CareDx and Collaborators Present Latest Cardiothoracic Advancements at the 2024 International Society for Heart and Lung Transplantation Meeting
- Apr 9th, 2024 11:00 am
How CareDx (CDNA) Stock Stands Out in a Strong Industry
- Apr 1st, 2024 12:40 pm
CareDx Appoints Bryan Riggsbee to Its Board of Directors
- Mar 11th, 2024 8:10 pm
CareDx Full Year 2023 Earnings: EPS Misses Expectations
- Mar 1st, 2024 10:51 am
CareDx, Inc (NASDAQ:CDNA) Q4 2023 Earnings Call Transcript
- Feb 29th, 2024 3:43 pm
Q4 2023 CareDx Inc Earnings Call
- Feb 29th, 2024 11:59 am
CareDx (CDNA) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
- Feb 29th, 2024 12:00 am
CareDx Inc (CDNA) Surpasses Revenue Expectations Despite Net Loss Expansion in 2023
- Feb 28th, 2024 9:57 pm
CareDx Announces Fourth Quarter and Full Year 2023 Financial Results
- Feb 28th, 2024 9:05 pm
CareDx to Participate in the Raymond James & Associates’ 45th Annual Institutional Investors Conference
- Feb 27th, 2024 9:05 pm
Unlocking Q4 Potential of CareDx (CDNA): Exploring Wall Street Estimates for Key Metrics
- Feb 26th, 2024 2:15 pm
CareDx to Report Fourth Quarter and Full Year 2023 Financial Results
- Feb 21st, 2024 9:05 pm
CareDx Showcases Digital Solutions and Pipeline in Cellular Transplant and Therapy Monitoring at the 2024 Tandem Meetings
- Feb 21st, 2024 12:00 pm
CareDx Issues Statement in Patent Infringement Case
- Jan 27th, 2024 2:45 am
CareDx (NASDAQ:CDNA shareholders incur further losses as stock declines 16% this week, taking three-year losses to 89%
- Jan 22nd, 2024 1:10 pm
CareDx Adds to AlloSure Kidney and HeartCare Utility and Clinical Data at 2024 American Society of Transplant Surgeons Winter Symposium
- Jan 11th, 2024 9:05 pm
CareDx Reports Preliminary Revenue Results for Fourth Quarter and Full Year 2023
- Jan 9th, 2024 12:00 pm
Scroll